Xedev at BIO-Europe 2026: Acceleration Biotech Innovation
This November, the global biopharma community gathers in Cologne, and Xedev will be at the center of the conversation. We are thrilled to participate in BIO-Europe 2026 from November 9th to 11th at the Cologne Messe.
As a specialist CDMO, Xedev understands that for biotech companies, the transition from a lead candidate to a manufacturable drug product is a critical milestone. We bridge the gap by providing “complexity made easy”—taking your innovative molecules and applying our core expertise to create robust, GMP-compliant clinical batches.
Let’s partner on the partneringONE platform and schedule a meeting with our team!